EDGEWISE THERAPEUTICS INC's ticker is EWTX and the CUSIP is 28036F105. A total of 73 filers reported holding EDGEWISE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,108,887 | -29.6% | 2,985,844 | -4.7% | 0.00% | -100.0% |
| Q2 2023 | $24,289,803 | +26.8% | 3,134,168 | +9.2% | 0.00% | 0.0% |
| Q1 2023 | $19,149,616 | -25.5% | 2,871,007 | -0.1% | 0.00% | 0.0% |
| Q4 2022 | $25,690,199 | +23.4% | 2,873,624 | +35.8% | 0.00% | 0.0% |
| Q3 2022 | $20,817,000 | +27.3% | 2,115,470 | +3.0% | 0.00% | 0.0% |
| Q2 2022 | $16,347,000 | -18.0% | 2,053,568 | -0.1% | 0.00% | 0.0% |
| Q1 2022 | $19,934,000 | -36.3% | 2,055,160 | +0.4% | 0.00% | 0.0% |
| Q4 2021 | $31,288,000 | +224.9% | 2,047,603 | +252.9% | 0.00% | – |
| Q3 2021 | $9,631,000 | -20.4% | 580,232 | +2.3% | 0.00% | – |
| Q2 2021 | $12,103,000 | +571.3% | 567,458 | +922.7% | 0.00% | – |
| Q1 2021 | $1,803,000 | – | 55,485 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,553,661 | $15,071,000 | 7.43% |
| Cormorant Asset Management, LP | 4,682,874 | $45,424,000 | 3.49% |
| Novo Holdings A/S | 5,587,207 | $54,196,000 | 2.86% |
| Orbimed Advisors | 13,944,680 | $135,263,000 | 2.19% |
| Opaleye Management Inc. | 303,000 | $2,939,000 | 0.91% |
| DAFNA Capital Management LLC | 356,750 | $3,460,000 | 0.90% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,933,137 | $38,151,000 | 0.85% |
| EcoR1 Capital, LLC | 2,359,808 | $22,890,000 | 0.72% |
| RA Capital Management | 2,613,623 | $25,352,000 | 0.55% |
| HighVista Strategies LLC | 59,733 | $579,000 | 0.37% |